Porphyromonas gingivalis infection-associated periodontal bone resorption is dependent on receptor activator of NF-κB ligand

Infection and Immunity

Volumn 81, Issue 5, 2013, Pages 1502-1509

  Han, Xiaozhe ^a   Lin, Xiaoping ^a,b   Yu, Xiaoqian ^a,c   Lin, Jiang ^a,d   Kawai, Toshihisa ^a   LaRosa, Karen B ^a   Taubman, Martin A ^a  

^a FORSYTH INSTITUTE   (United States)

^b CHINA MEDICAL UNIVERSITY   (China)

^c PEKING UNIVERSITY SCHOOL AND HOSPITAL OF STOMATOLOGY   (China)

^d HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G; OSTEOCLAST DIFFERENTIATION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; CHRONIC PERIODONTITIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; IMMUNOGLOBULIN BLOOD LEVEL; LYMPHOCYTE PROLIFERATION; NONHUMAN; OSTEOLYSIS; PORPHYROMONAS GINGIVALIS; PORPHYROMONAS GINGIVALIS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT;

ALVEOLAR BONE LOSS; ANIMALS; BACTEROIDACEAE INFECTIONS; BONE RESORPTION; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GINGIVA; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LYMPHOCYTES; MAXILLARY DISEASES; OSTEOCLASTS; PORPHYROMONAS GINGIVALIS; RANK LIGAND; RATS;

EID: 84877795867     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00043-13     Document Type: Article

References (35)

1. Han X, Kawai T, Eastcott JW, Taubman MA. 2006. Bacterial-responsive B lymphocytes induce periodontal bone resorption. J. Immunol. 176:625-631.
2. Michalek SM, Katz J, Childers NK, Martin M, Balkovetz DF. 2002. Microbial/host interactions: mechanisms involved in host responses to microbial antigens. Immunol. Res. 26:223-234.
3. Taubman MA, Kawai T. 2001. Involvement of T-lymphocytes in periodontal disease and in direct and indirect induction of bone resorption. Crit. Rev. Oral Biol. Med. 12:125-135.
4. Zadeh HH, Nichols FC, Miyasaki KT. 1999. The role of the cell-mediated immune response to Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in periodontitis. Periodontol 2000 20:239-288.
5. Kawai T, Eisen-Lev R, Seki M, Eastcott JW, Wilson ME, Taubman MA. 2000. Requirement of B7 costimulation for Th1-mediated inflammatory bone resorption in experimental periodontal disease. J. Immunol. 164: 2102-2109.
6. Kawai T, Shimauchi H, Eastcott JW, Smith DJ, Taubman MA. 1998. Antigen direction of specific T-cell clones into gingival tissues. Immunology 93:11-19.
7. Dorner T, Burmester GR. 2003. The role of B cells in rheumatoid arthritis: mechanisms and therapeutic targets. Curr. Opin. Rheumatol. 15:246-252.
8. Fournier C. 2005. Where do T cells stand in rheumatoid arthritis? Joint Bone Spine 72:527-532.
9. Takayanagi H. 2009. Osteoimmunology and the effects of the immune system on bone. Nat. Rev. Rheumatol. 5:667-676.
10. Rogers JE, Li F, Coatney DD, Otremba J, Kriegl JM, Protter TA, Higgins LS, Medicherla S, Kirkwood KL. 2007. A p38 mitogen-activated protein kinase inhibitor arrests active alveolar bone loss in a rat periodontitis model. J. Periodontol. 78:1992-1998.
11. Taubman MA, Valverde P, Han X, Kawai T. 2005. Immune response: the key to bone resorption in periodontal disease. J. Periodontol. 76:2033-2041.
12. Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, Morony S, Oliveira-dos-Santos AJ, Van G, Itie A, Khoo W, Wakeham A, Dunstan CR, Lacey DL, Mak TW, Boyle WJ, Penninger JM. 1999. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397:315-323.
13. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ. 1998. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165-176.
14. Udagawa N, Takahashi N, Jimi E, Matsuzaki K, Tsurukai T, Itoh K, Nakagawa N, Yasuda H, Goto M, Tsuda E, Higashio K, Gillespie MT, Martin TJ, Suda T. 1999. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor. Bone 25:517-523.
15. Kong YY, Boyle WJ, Penninger JM. 1999. Osteoprotegerin ligand: a common link between osteoclastogenesis, lymph node formation and lymphocyte development. Immunol. Cell Biol. 77:188-193.
16. Toraldo G, Roggia C, Qian WP, Pacifici R, Weitzmann MN. 2003. IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and tumor necrosis factor alpha from T cells. Proc. Natl. Acad. Sci. U. S. A. 100:125-130.
17. Wyzga N, Varghese S, Wikel S, Canalis E, Sylvester FA. 2004. Effects of activated T cells on osteoclastogenesis depend on how they are activated. Bone 35:614-620.
18. Kawai T, Matsuyama T, Hosokawa Y, Makihira S, Seki M, Karimbux NY, Goncalves RB, Valverde P, Dibart S, Li YP, Miranda LA, Ernst CW, Izumi Y, Taubman MA. 2006. B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. Am. J. Pathol. 169:987-998.
19. Valverde P, Kawai T, Taubman MA. 2004. Selective blockade of voltagegated potassium channels reduces inflammatory bone resorption in experimental periodontal disease. J. Bone Miner. Res. 19:155-164.
20. Teng YT, Nguyen H, Gao X, Kong YY, Gorczynski RM, Singh B, Ellen RP, Penninger JM. 2000. Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. J. Clin. Invest. 106:R59-67.
21. Theill LE, Boyle WJ, Penninger JM. 2002. RANK-L and RANK: T cells, bone loss, and mammalian evolution. Annu. Rev. Immunol. 20:795-823.
22. Taubman MA, Kawai T, Han X. 2007. The new concept of periodontal disease pathogenesis requires new and novel therapeutic strategies. J. Clin. Periodontol. 34:367-369.
23. Cochran DL. 2008. Inflammation and bone loss in periodontal disease. J. Periodontol. 79:1569-1576.
24. Lorenzo J, Horowitz M, Choi Y. 2008. Osteoimmunology: interactions of the bone and immune system. Endocr. Rev. 29:403-440.
25. Walsh MC, Kim N, Kadono Y, Rho J, Lee SY, Lorenzo J, Choi Y. 2006. Osteoimmunology: interplay between the immune system and bone metabolism. Annu. Rev. Immunol. 24:33-63.
26. Sakellari D, Menti S, Konstantinidis A. 2008. Free soluble receptor activator of nuclear factor-B ligand in gingival crevicular fluid correlates with distinct pathogens in periodontitis patients. J. Clin. Periodontol. 35: 938-943.
27. Wara-aswapati, N, Surarit R, Chayasadom A, Boch JA, Pitiphat W. 2007. RANKL upregulation associated with periodontitis and Porphyromonas gingivalis. J. Periodontol. 78:1062-1069.
28. Baker PJ, Evans RT, Roopenian DC. 1994. Oral infection with Porphyromonas gingivalis and induced alveolar bone loss in immunocompetent and severe combined immunodeficient mice. Arch. Oral Biol. 39:1035-1040.
29. Gibson FC, III, Genco CA. 2001. Prevention of Porphyromonas gingivalisinduced oral bone loss following immunization with gingipain R1. Infect. Immun. 69:7959-7963.
30. Liang S, Krauss JL, Domon H, McIntosh ML, Hosur KB, Qu H, Li F, Tzekou A, Lambris JD, Hajishengallis G. 2011. The C5a receptor impairs IL-12-dependent clearance of Porphyromonas gingivalis and is required for induction of periodontal bone loss. J. Immunol. 186:869-877.
31. Persson GR. 2005. Immune responses and vaccination against periodontal infections. J. Clin. Periodontol 32(Suppl 6):39-53.
32. Lin X, Han X, Kawai T, Taubman MA. 2011. Antibody to receptor activator of NF-B ligand ameliorates T cell-mediated periodontal bone resorption. Infect. Immun. 79:911-917.
33. Khosla S. 2005. Magic bullets to kill nasty osteoclasts. Endocrinology 146:3233-3234.
34. Lewiecki EM, Miller PD, McClung MR, Cohen SB, Bolognese MA, Liu Y, Wang A, Siddhanti S, Fitzpatrick LA. 2007. Two-year treatment with denosumab(AMG162) in a randomized phase 2 study of postmenopausal women with low BMD. J. Bone Miner. Res. 22:1832-1841.
35. McClung MR, Lewiecki EM, Cohen SB, Bolognese MA, Woodson GC, Moffett AH, Peacock M, Miller PD, Lederman SN, Chesnut CH, Lain D, Kivitz AJ, Holloway DL, Zhang C, Peterson MC, Bekker PJ. 2006. Denosumab in postmenopausal women with low bone mineral density. N. Engl. J. Med. 354:821-831.